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OBJECTIVE: The aim of this study was to compare female sexual function after surgical treatment of anterior vaginal
prolapse with either small intestine submucosa grafting or traditional colporrhaphy.
METHODS: Subjects were randomly assigned, preoperatively, to the small intestine submucosa graft (n = 29) or
traditional colporrhaphy (n=27) treatment group. Postoperative outcomes were analyzed at 12 months. The Female
Sexual Function Index questionnaire was used to assess sexual function. Data were compared with independent
samples or a paired Student’s t-test. ClinicalTrials.gov: NCT00827528.
RESULTS: In the small intestine submucosa group, the total mean Female Sexual Function Index score increased from
15.5¡7.2 to 24.4¡7.5 (p,0.001). In the traditional colporrhaphy group, the total mean Female Sexual Function
Index score increased from 15.3¡6.8 to 24.2¡7.0 (p,0.001). Improvements were noted in the domains of desire,
arousal, lubrication, orgasm, satisfaction, and pain. There were no differences between the two groups at the 12-
month follow-up.
CONCLUSIONS: Small intestine submucosa repair and traditional colporrhaphy both improved sexual function
postoperatively. However, no differences were observed between the two techniques.
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INTRODUCTION
Female Sexual Dysfunction (FSD) is multifactorial and
involves physical, social, and psychological dimensions.
FSD is defined as disorders of desire, arousal, orgasm, or
pain that could cause emotional distress (1). Earlier studies
have shown that this problem affects 39-53% of women in
the general population (2-4). Women with pelvic floor
disorders (PFDs), such as pelvic organ prolapse (POP) and
stress urinary incontinence (SUI), commonly have problems
related to sexual function (5-7).
More than 225,000 surgical procedures are performed for
POP each year in the USA, and the estimated cost of these
surgeries is over US $1 billion (8-10). The lifetime risk of
prolapse surgery has been estimated to be approximately
11%, and 30% of patients undergo re-operation for recurrent
prolapse (11). In the USA, approximately 150,000 surgeries
are performed every year for cystocele and/or rectocele
repairs (10,12). The anterior compartment is the most
common site of recurrence, with failure rates as high as
40% (12).
Despite anatomical and functional improvements, Pauls
et al. (13) showed that sexual function was unchanged
after vaginal reconstructive surgery. They concluded that
the lack of benefit may be attributable to postoperative
dyspareunia. This is a controversial issue, as some authors
have shown improvements (14,15) and others have not
(16).
Despite the widespread use of mesh in surgery to correct
prolapse, few safety and efficacy studies have been pub-
lished. Therefore, the use of mesh during vaginal repair
procedures remains controversial. Uncontrolled studies have
reported significant problems associated with the use of
mesh for vaginal repair (17). Previous studies are difficult to
assess and compare for several reasons, namely the incon-
sistent use of primarily unvalidated, self-made question-
naires; the lack of a definition for sexual function and
dysfunction; and the failure to assess impacts on quality of
life (18).
The aim of this study was to assess sexual function
using a validated sexual function questionnaire adminis-
tered following vaginal surgery for anterior vaginal wall
prolapse.
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MATERIALS AND METHODS
We included pre- and post-menopausal women who were
referred for vaginal surgery and who had at least stage II
anterior vaginal wall prolapse (point Ba$+1). Patients were
randomly assigned to one of two groups: SIS graft or
traditional anterior colporrhaphy.
Subjects were excluded if they had undergone pelvic
radiotherapy or if they had pelvic sepsis, gynecologic
cancer, vulvovaginal infections, a current history of smok-
ing or alcoholism, any chronic disabling diseases, or
hypertension.
All patients underwent a standard physical examination
that included pelvic organ prolapse quantification (POP-Q)
(19). The examination included POP-Q in the gynecological
position with an empty bladder. A Valsalva maneuver or
cough demonstrated the maximum descent of the involved
pelvic organ.
Preoperatively and at 12 months postoperatively, patients
were asked to complete the Female Sexual Function Index
(FSFI) questionnaire (20), which was translated to Portuguese
and validated for Brazilian women (21,22). The FSFI is used
to investigate problems with sexual function in the previous
four weeks. The FSFI is a comprehensive, 19-item tool that
assesses six domains of sexual function, namely desire,
arousal, lubrication, orgasm, satisfaction, and pain. The
questionnaire provides a comprehensive assessment of
baseline and postoperative changes. To calculate each
domain score, the scores of the related items are added,
and the result is multiplied by a coefficient. Within the
domains, a score of zero indicates that the patient reported no
sexual intercourse in the previous four weeks. Consequently,
the maximum domain score is 6, and the lowest score is 0 for
four domains and 0.8 and 1.2, respectively, for two domains.
The total FSFI score is calculated by adding the mean scores
of all six domains. Higher scores indicate better sexual
function. Total FSFI scores range from a low of 2 to a high of
36. The FSFI is self-administered.
Multichannel urodynamics were performed on subjects
who had urinary incontinence prior to the surgery. We used
clinical patterns to evaluate menopausal status; namely,
women who reported current and regular periods were
defined as premenopausal, while women who reported
more than 12 months of amenorrhea were defined as
postmenopausal. We used methods and definitions from the
International Continence Society subcommittee for the
standardization of terminology (23).
Figure 1 shows a flow chart of the progression of patients
through the study. All eligible women who agreed to
participate in the study and who provided written informed
consent were enrolled. After they were enrolled by a
physician investigator, subjects were assigned to the two
treatment groups: SIS and traditional repair. One week
before surgery, individuals were randomized by a compu-
ter-generated list that was prepared by the Biostatistics
Center at the Federal University of Sa˜o Paulo. The list was
centrally maintained. There were no drop-outs in the
follow-up, and the data were analyzed with an intention-
to-treat analysis. The preoperative assessments were con-
ducted by one investigator. After the surgery, the examiners
were blinded to the surgical intervention that each subject
received. The postoperative follow-ups were performed by
three investigators who were also blinded to the group
assignments.
This study was a prospective and randomized study that
was approved by a local ethics committee and was
registered at ClinicalTrials.gov (NCT00827528). The primary
outcome was the anatomical success of the surgery, which
was defined as the absence, at the 12-month follow-up, of
POP-Q stage II or higher prolapse (point Ba). The secondary
objective was to measure quality-of-life outcomes and
sexual function. The two surgical techniques, the outcomes
regarding anatomical cure, the P-QoL questionnaire and the
complications have been previously reported (24). Similar to
Pauls’ (13) retrospective analysis, a sample size of 18 women
in each group was chosen to detect a difference of 5 points
in the FSFI score with 90% power.
All numerical data were expressed as the means¡stan-
dard deviations. To detect preoperative intergroup differ-
ences, we used a Mann-Whitney U test for continuous
variables and a chi-square test for categorical variables. Data
were normally distributed, which enabled the use of an
independent samples t-test to assess the postoperative
difference between the two groups and a paired Student’s
t-test to assess the same group before and after the surgery.
The level of significance was 0.05.
RESULTS
Preoperatively, the groups were homogeneous with
respect to age, body mass index, parity, hormonal status,
stage of anterior prolapse, previous surgery for prolapse,
previous stress urinary incontinence and previous hyster-
ectomy (Table 1).
Scores in the FSFI domains were also homogeneous
preoperatively (Table 2).
There were 23 (79.3%) sexually active patients in the SIS
group and 22 (81.4%) in the TC group. All of the patients
were in heterosexual relationships.
At the 12-month follow-up, both groups had significantly
improved sexual quality of life. In the SIS group, the total
mean FSFI score increased from 15.5¡7.2 to 24.9¡7.5
(p,0.001). In the TC group, the total mean FSFI score
increased from 15.3¡6.8 to 24.2¡7.0 (p,0.001). Statistically
significant improvements were noted in all domains,
including desire, arousal, vaginal lubrication, ability to
achieve orgasm, sexual satisfaction, and pain. However,
there were no differences between the groups (Table 2).
Women were also questioned, preoperatively and at 12
months, about dyspareunia. At the 12-month follow-up, 5 of
the 29 (17.2%) patients in the SIS group and 4 of the 27
(14.8%) patients in the traditional repair group reported
dyspareunia (p= 0.90). There were no infections or graft
erosions that could have caused the dyspareunia.
DISCUSSION
FSD has become a popular research area because of its
importance to quality of life. However, the routine
identification of FSD is still lacking (25). Surgery for
prolapse and urinary incontinence does not necessarily
ensure optimal sexual function, and conflicting results have
been reported (13-16).
Using the FSFI at 12 months after the operation, our
results showed that SIS graft repair and traditional
colphorraphy resulted in improvements in sexual quality
of life; however, no differences were observed between the
two techniques.
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There are few studies on the sexual outcomes of anterior
colporrhaphy compared with graft-augmented repair. Some
authors have agreed that cystocele repair is not associated
with dyspareunia or impaired sexual function, but this issue
is controversial in the literature (26).
Anterior repair appears to have a negative effect on
sexual function only when it is combined with another
procedure. Colombo et al. assessed 23 women who had an
anterior repair and found that 56% had mild-to-severe
postoperative dyspareunia; however, the patients also had a
posterior repair and perineorrhaphy (26,27).
Data from one trial suggested a reduction in dyspareunia,
from 30% preoperatively to 22% postoperatively, in a
comparison of three surgical techniques of anterior colpor-
rhaphy (28). Another trial compared anterior colporrhaphy
with and without porcine dermis inlay (Pelvicol). At the
one-year follow-up, there were no differences in dyspar-
eunia between the groups (29).
Graft anterior repair exposure has ranged from 0 to 30%;
however, the data regarding dyspareunia and sexual
dysfunction are insufficient (17). Jia et al. reported that
7.1-12.8% of patients had de novo dyspareunia after surgical
Figure 1 - Flow chart of patient progression through the study.
Table 1 - Baseline data. Values are presented as the means
(¡standard deviation) or the number of subjects (n).
SIS (n = 29)
Traditional repair
(n = 27) p-value
Age (y) 53.8¡9.7 56.3¡13.0 0.42
Parity 4.3¡1.8 4.0¡2.1 0.68
Body mass index 27.3¡4.9 27.5¡4.5 0.89
Hormonal status
Postmenopausal 19 (65.5%) 13 (48.2%)
Premenopausal 10 (34.5%) 14 (51.8%) 0.44
POP-Q Stage
II 9 (31.0%) 13 (48.2%)
III 19 (65.5%) 12 (44.4%)
IV 1 (3.5%) 2 (7.4%) 0.27
Prior POP surgery 7 (24.1%) 7 (25.9%) 0.87
Prior SUI surgery 5 (17.2%) 3 (11.1%) 0.78
Prior hysterectomy 3 (10.3%) 1 (3.7%) 0.65
POP-Q: pelvic organ prolapse quantification.
SUI: stress urinary incontinence.
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repair of POP using graft augmentation (30). Foon et al. (31)
concluded that erosions and dyspareunia were common
adverse events in the surgical treatment of anterior vaginal
wall prolapse with adjuvant materials.
In a cross-sectional study using the FSFI questionnaire,
Najafabady et al. (32) assessed the prevalence and asso-
ciated factors of anorgasmia among 1,200 reproductive-age
Iranian women. Compared with the normal orgasm group,
the authors found that 26.3% of the anorgasmic and most of
the anorgasmic women were highly unsatisfied with their
sexual relationship.
There were several limitations to the present study. The
study was initially intended for a 12-month follow-up. A
longer follow-up could potentially identify changes in
sexual function and could demonstrate a possible degrada-
tion of SIS, which has been noted in previous SIS slings used
for stress urinary incontinence. The sample size was
calculated based on the primary objective of achieving an
anatomical cure. The sample size may have been inadequate
to detect small differences between the groups, and the
power calculation was suboptimal, especially for the FSFI
scores.
Although the surgical procedure was standardized, there
may have been variations in the surgical technique that was
employed by different surgeons. However, this would more
closely represent expected outcomes in actual clinical
practice compared with trials employing only one surgeon.
Another important matter is that the FSFI questionnaire
that was utilized to assess the sexual function in women
with PFDs has some limitations. The FSFI questionnaire is
not specifically designed to assess changes in sexual health
that are caused by PFDs. Therefore, it may not be sensitive
to meaningful changes in sexual function in our population.
Additionally, the questionnaires do not screen for sexual
activity, which may underestimate the impact of PFDs on
sexual function, as women with severe dysfunction may
elect to become sexually inactive (18).
Rigorous RCTs are required to determine the comparative
efficacy of grafts and their optimal place in clinical practice.
Functional results are important as outcome measures of
anatomical results in the assessment of pelvic floor surgery.
Following pelvic floor surgery, sexual function assessment
tools are needed to define clear outcomes for sexual function.
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